22 July, 2025
top-asx-shares-rated-as-buys-life360-and-xero-in-focus

As the Australian Securities Exchange (ASX) continues to present a plethora of investment opportunities, two companies have emerged as particularly promising according to broker ratings. Life360 and Xero Ltd are currently spotlighted as potential buys, each offering unique growth prospects that could enhance a balanced investment portfolio.

The announcement comes as investors are increasingly seeking robust options amidst fluctuating market conditions. Both companies have demonstrated resilience and strategic foresight, making them attractive to analysts and investors alike.

Life360: Disrupting Markets with Growth Potential

Life360, a location technology company, has caught the attention of Bell Potter, a leading brokerage firm. The firm highlights Life360’s strong growth outlook, driven by its expanding subscriber base and potential to disrupt traditional markets.

Large and resilient subscriber base: Life360 has approximately 2.4 million paying circles, a key metric for subscriber numbers, and has grown this base by 23% in 2022, 21% in 2023, and is projected to grow by 25% in 2024. This growth underscores the resilience of its subscriber base, particularly as market conditions normalize post-COVID-19.

Life360’s ability to leverage its user base for market disruption is noteworthy. The company has already made strides with its subscription-based product, Driver Protect, in the roadside assistance sector. Future opportunities for Life360 include potential expansions into insurance, item and pet tracking, senior monitoring, home security, and identity theft protection.

Bell Potter has set a buy rating with a price target of $37.50 on Life360’s shares, reflecting confidence in the company’s strategic direction and growth potential.

Xero Ltd: Strengthening US Presence Through Strategic Acquisition

Cloud accounting platform provider Xero Ltd is another ASX share garnering attention. The company recently announced a significant acquisition aimed at bolstering its US operations, a move that has been positively received by analysts at Macquarie.

Macquarie’s perspective: “Melio improves Xero’s ability to grow in the US, Xero’s largest Total Addressable Market (TAM) segment at US$29 billion. Medium-term, the larger risk to Xero is an inability to deliver on US growth, not accretion/dilution on a 1/2 year forward time horizon. This acquisition shores up the 5-10 year growth story. Management is making data-driven decisions that invariably lead to better capital allocation outcomes. We have high conviction in the >12-month story. However, with upcoming brand reinvestment, any downside from cost growth presents a buying opportunity. Reiterate Outperform.”

Macquarie has reaffirmed its outperform rating on Xero’s shares, setting a price target of $204.00. The acquisition is seen as a strategic move to secure long-term growth in a competitive market.

Implications for Investors

The positive ratings for Life360 and Xero reflect broader trends in the technology and financial services sectors, where innovation and strategic market positioning are key drivers of success. Investors looking to diversify their portfolios may find these companies’ growth strategies and market potential particularly appealing.

As both companies continue to expand and innovate, they represent significant opportunities for those willing to invest in their long-term growth narratives. The focus on technological advancement and market disruption positions them well in the current economic climate.

With the ASX offering a range of investment options, Life360 and Xero stand out for their strategic initiatives and potential for sustained growth. Investors are encouraged to consider these shares as part of a diversified investment strategy.